Concepedia

Ling Tian

LT

Statistics

Publications

6

Citations

313

H-Index

6

Active since

2012

Affiliations

Shanghai First People's Hospital(Current)

Duke University

Shanghai Jiao Tong University

Jinan University

Duke Medical Center

Ling Tian is an author at Shanghai First People's Hospital specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2012–2021

6

Publications

6

HMGB1 released by irradiated tumor cells promotes living tumor cell proliferation via paracrine effect

Sijia He, Jin Cheng, Lianhui Sun et al. · Cell Death and Disease · 2018 · 128 citations · Full text

, , +17

Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer

Zhengxiang Zhang, Min Wang, Ling Zhou et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 74 citations · Full text

, , +15

Novel prognostic markers for patients with triple-negative breast cancer

Ling Zhou, Ke Li, Yanli Luo et al. · Human Pathology · 2013 · 50 citations

, , +11

Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition

Zhen Shu, Zhen Li, Huanhuan Huang et al. · Oncogene · 2020 · 26 citations

, , +17

mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer

Ling Tian, Congcong Chen, Yanguan Guo et al. · Neoplasia · 2021 · 18 citations · Full text

, , +15

1–5 of 6